Search Results - "Woll, Michael M"

Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 by Peoples, George E, Holmes, Jarrod P, Hueman, Matthew T, Mittendorf, Elizabeth A, Amin, Asna, Khoo, Steven, Dehqanzada, Zia A, Gurney, Jennifer M, Woll, Michael M, Ryan, Gayle B, Storrer, Catherine E, Craig, Dianna, Ioannides, Constantin G, Ponniah, Sathibalan

“…Purpose: E75 is an immunogenic peptide from the HER2/ neu protein, which is overexpressed in many breast cancer patients. We have conducted two overlapping E75…”
Get full text

Surgical Critical Care for the Trauma Patient with Cardiac Disease by Woll, Michael M., MD, Maerz, Linda L., MD

“…The elderly population is rapidly increasing in number. Therefore, geriatric trauma is becoming more prevalent. All practitioners caring for geriatric trauma…”
Get full text

Phase I Clinical Trial of a HER-2/neu Peptide (E75) Vaccine for the Prevention of Prostate-Specific Antigen Recurrence in High-Risk Prostate Cancer Patients by HUEMAN, Matthew T, DEHQANZADA, Zia A, PONNIAH, Sathibalan, PEOPLES, George E, NOVAK, Thomas E, GURNEY, Jennifer M, WOLL, Michael M, RYAN, Gayle B, STORRER, Catherine E, FISHER, Christine, MCLEOD, David G, IOANNIDES, Constantine G

“…Purpose: The E75 peptide is an immunogenic peptide from the HER-2/ neu protein that is substantially expressed in prostate cancer. We are conducting a clinical…”
Get full text

Longterm Followup Assessment of a HER2/ neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients by Gates, Jeremy D., MD, Carmichael, Mark G., MD, Benavides, Linda C., MD, Holmes, Jarrod P., MD, Hueman, Matthew T., MD, Woll, Michael M., MD, Ioannides, Constantine G., PhD, Robson, Craig H., MD, McLeod, David G., MD, Ponniah, Sathibalan, MD, Peoples, George E., MD

“…Background E75 is an immunogenic peptide from the HER2/ neu protein that is expressed in prostate cancer. High-risk prostate cancer (HRPC) patients…”
Get full text

Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients by Woll, Michael M, Fisher, Christine M, Ryan, Gayle B, Gurney, Jennifer M, Storrer, Catherine E, Ioannides, Constantin G, Shriver, Craig D, Moul, Judd W, McLeod, David G, Ponniah, Sathibalan, Peoples, George E

“…HER2/neu is a proto-oncogene and a member of the epidermal growth factor receptor family of proteins that is overexpressed in numerous types of human cancer…”
Get full text

Preclinical testing of a peptide-based, HER2/neu vaccine for prostate cancer by Woll, Michael M, Hueman, Matthew T, Ryan, Gayle B, Ioannides, Constantin G, Henderson, Charles G, Sesterhan, Isabelle A, Shrivasta, Shiv, McLeod, David G, Moul, Judd W, Peoples, George E

“…The HER2/neu protein is over-expressed in multiple epithelial tumors and the source of immunogenic peptides currently under investigation in vaccine trials in…”
Get more information

Bilateral Spontaneous Dissection of the Internal Carotid Arteries: A Case Report by Woll, Michael M., Goff, James M., Gillespie, David L., Minken, Stanley L.

“…A 41-year-old African American man presented with an acute stroke secondary to bilateral spontaneous internal carotid artery dissections following exercise…”
Get full text